Both in Pharmaceuticals
Minerva Neurosciences vs Spruce Biosciences
Over the past year NERV returned −7.1% and SPRB returned −74.7%; their daily moves had a correlation of 0.01.
NERV −7.1% SPRB −74.7%Growth of $1, one year, split-adjusted
| Metric | NERV | SPRB |
|---|---|---|
| Price | $2.35 | $39.65 |
| Market cap | $112.2M | $114.0M |
| Today | −2.89% | −4.39% |
| 1 month | −32.1% | −26.4% |
| 6 months | −65.1% | −43.6% |
| Year to date | −41.5% | −54.5% |
| 1 year | −6.4% | −75.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $75.3M | $89.2M |
| Dividend yield | — | — |
| Volatility (60d) | 81.2% | 63.1% |
| Short % of float | 6.1% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).